首頁 > 市場調查報告書 > 醫療設備

感染疾病

市場調查報告書

商品編碼

1824210

全球感染疾病控制市場 - 預測 2025-2030

Global Infection Control Market - Forecasts from 2025 to 2030

出版日期: 2025年08月24日 | 出版商:

Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

感染疾病預防措施的市場規模

感染疾病控制市場預計將從 2025 年的 504.11 億美元成長到 2030 年的 620.63 億美元，複合年成長率為 4.25%。

感染疾病控制市場涵蓋旨在最大程度降低感染和病毒傳播風險的實踐和程序，尤其是在醫院和醫療機構中。該市場致力於預防透過人際接觸、受污染表面和空氣傳播的細菌和病毒性疾病，是保障病患安全和設施管理的關鍵醫療基礎設施。

市場基礎及臨床意義

感染疾病控制措施是預防醫院內獲得性感染 (HAI) 的關鍵措施。醫院內獲得性感染發生在病人住院期間，是醫療機構導致死亡的主要原因。這些感染疾病通常源自於診斷過程共用用醫療設備，並可能導致人工呼吸器相關性肺炎、導管相關性尿道感染、中心靜脈導管相關性血流感染疾病、手術部位感染疾病。

院內感染 (HAI) 的發生受患者免疫系統狀況、機構感染疾病控制措施以及醫院環境中傳染源的存在的影響。患者年齡和住院時間較長會顯著增加感染風險，常見的與院內感染相關的細菌包括大腸桿菌、耐甲氧西林金黃色葡萄球菌 (MRSA)、克雷伯氏菌、腸球菌和假單胞菌。

市場成長的關鍵驅動力

預防醫院內感染

醫院感染 (HAI) 發病率的上升是市場成長的根本驅動力，因為醫療機構優先考慮滅菌和消毒，以防止病毒在患者之間傳播。最常見的感染疾病包括血流感染、肺炎、尿道感染和手術部位感染，其中手術部位感染是最大的成本促進因素，因為它會增加住院時間和相關的診斷檢查。

醫療機構使用先進的設備和程序實施全面的消毒通訊協定，以最大限度地降低感染風險、改善患者治療效果並降低相關的醫療成本。

手術和人口趨勢

由於老年人口不斷成長以及慢性病的流行，外科手術數量不斷增加，推動了市場需求的持續成長。老年人群更容易受到感染，因此需要加強感染疾病控制措施，並針對這群脆弱的患者群制定特殊通訊協定。

整合技術進步

滅菌設備的技術進步，包括電子束滅菌和環氧乙烷滅菌的重新引入，正透過提高滅菌效果和效率來支持市場擴張。這些進步使醫療機構能夠實施更有效的感染疾病控制通訊協定，同時滿足醫療設備和表面的多樣化滅菌需求。

細分市場和應用領域

市場細分包括醫療機構、製藥公司和醫療設備製造商的滅菌服務、設備製造和消耗品。食品滅菌和消毒應用將市場範圍從醫療保健擴展到食品安全和加工行業。

製藥公司、醫院和醫療設備製造商之間的外包趨勢為專業滅菌服務供應商創造了機會，同時透過服務多樣化支持了整體市場的成長。

區域市場動態

在預測期內，北美將保持最大的市場佔有率，這得益於先進的醫療基礎設施、監管要求以及整個醫療系統完善的感染疾病控制通訊協定。

市場限制與挑戰

對化學消毒劑安全性的擔憂

表面消毒劑、消毒液和滅菌劑的毒性以及接觸化學消毒劑的副作用限制了市場的發展。次氯酸鈉雖然能有效對抗血源性病原體，但其腐蝕性強，並具有呼吸道刺激性，對清潔人員和建築物居住者構成風險。

對環境釋放毒性的擔憂限制了消毒劑的使用，尤其是在對環境永續解決方案的需求日益成長的情況下。消毒劑和殺菌劑缺乏綠色認證，限制了市場發展，製造商紛紛開發替代品，例如不含丁基、pH值中性的季銨鹽和過氧化氫基配方。

競爭格局

市場領導者包括生產醫療設備、滅菌系統和消毒產品的老字型大小企業，例如 3M、Belimed、Cantel Medical、MMM Group、Sterigenics International LLC、STERIS plc、Matachana Group、Olympus Corporation 和 Medtronic。

戰略意義

受醫院感染預防需求、人口結構趨勢和技術進步的推動，感染疾病控制市場正面臨巨大的成長機會。成功的關鍵在於平衡感染疾病控制的有效性與環境永續性，同時透過創新產品開發和永續性替代解決方案來解決與化學消毒劑相關的安全問題。

本報告的主要優點

深刻分析：獲得深入的市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場，涵蓋主要地區和新興地區。
競爭格局：了解主要企業所採用的策略策略，並了解正確策略的市場滲透潛力。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力來制定策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說，既有利又划算。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

The infection control market encompasses practices and procedures designed to minimize infection and virus transmission risks, particularly in hospitals and healthcare facilities. This market addresses disease prevention from bacteria and viruses that spread through human-to-human contact, contaminated surfaces, and airborne transmission, representing critical healthcare infrastructure for patient safety and facility management.

Market Foundation and Clinical Significance

Infection control practices serve as essential safeguards against hospital-acquired infections (HAIs), which occur during patient facility stays and represent primary mortality causes in healthcare settings. These infections typically result from shared medical equipment usage during diagnostic procedures, leading to conditions including ventilator-associated pneumonia, catheter-associated urinary tract infections, central line-associated bloodstream infections, and surgical-site infections.

HAI development depends on patient immune system status, facility infection control practices, and infectious agent presence within hospital environments. Patient age and extended facility stays contribute significantly to infection risk, while common bacteria associated with HAIs include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and Pseudomonas species.

Primary Market Growth Drivers

Hospital-Acquired Infections Prevention

Growing HAI incidence represents the fundamental market driver, as healthcare facilities prioritize sterilization and disinfection practices to prevent patient-to-patient transmission. The most common infections include bloodstream infections, pneumonia, urinary tract infections, and surgical site infections, with surgical site infections representing the largest cost component due to prolonged hospitalization requirements and associated diagnostic testing.

Healthcare facilities implement comprehensive sterilization protocols using advanced equipment and procedures to minimize transmission risks and improve patient outcomes while reducing associated healthcare costs.

Surgical Procedures and Demographic Trends

Increasing surgical procedure volumes coupled with growing geriatric populations and chronic disease prevalence drive sustained market demand. Aging populations demonstrate higher infection susceptibility, requiring enhanced infection control measures and specialized protocols for vulnerable patient populations.

Technological Advancement Integration

Technological improvements in sterilization equipment, including E-beam sterilization and ethylene oxide sterilization reintroduction, support market expansion through enhanced efficacy and efficiency. These advances enable healthcare facilities to implement more effective infection control protocols while addressing diverse sterilization requirements across medical devices and facility surfaces.

Market Segmentation and Applications

The market segments include sterilization services, equipment manufacturing, and consumable products for healthcare facilities, pharmaceutical companies, and medical device manufacturers. Food sterilization and disinfection applications expand market scope beyond healthcare into food safety and processing industries.

Outsourcing trends among pharmaceutical companies, hospitals, and medical device manufacturers create opportunities for specialized sterilization service providers while supporting overall market growth through service diversification.

Geographic Market Dynamics

North America maintains the largest market share during the forecast period, supported by advanced healthcare infrastructure, regulatory requirements, and established infection control protocols across healthcare systems.

Market Constraints and Challenges

Chemical Disinfectant Safety Concerns

Adverse effects from chemical disinfectant exposure present ongoing market constraints due to toxic properties in surface disinfectants, sanitizers, and sterilizers. Sodium hypochlorite, while effective against blood-borne pathogens, demonstrates high corrosiveness and respiratory irritant properties, creating hazards for cleaning personnel and building occupants.

Environmental release toxicity concerns limit disinfectant usage, particularly given increasing demand for environmentally sustainable solutions. The absence of green certification for disinfectants and sterilizers restricts market expansion as manufacturers develop alternatives including butyl-free, pH-neutral quaternary, and hydrogen peroxide-based formulations.

Competitive Landscape

Market leadership includes established companies such as 3M, Belimed, Cantel Medical, MMM Group, Sterigenics International LLC, STERIS plc, Matachana Group, Olympus Corporation, and Medtronic, which manufacture healthcare equipment, sterilization systems, and disinfecting products.

Strategic Implications

The infection control market presents substantial growth opportunities driven by HAI prevention requirements, demographic trends, and technological advancement. Success requires balancing infection control efficacy with environmental sustainability while addressing safety concerns associated with chemical disinfectants through innovative product development and green alternative solutions.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Infection Control Market Segments:

By Products

Disinfectants
Sterilization
Low-Temperature Sterilization
Heat Sterilization
Contract Sterilization

By End-User Industry

Healthcare
Pharmaceuticals
Food and Beverage
Chemical

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL INFECTION CONTROL MARKET BY PRODUCTS

5.1. Introduction
5.2. Disinfectants
5.3. Sterilization
5.4. Low-Temperature Sterilization
5.5. Heat Sterilization
5.6. Contract Sterilization

6. GLOBAL INFECTION CONTROL MARKET BY END-USER INDUSTRY

6.1. Introduction
6.2. Healthcare
6.3. Pharmaceuticals
6.4. Food and Beverage
6.5. Chemical

7. GLOBAL INFECTION CONTROL MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. USA
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Others
7.4. Europe
- 7.4.1. Germany
- 7.4.2. France
- 7.4.3. United Kingdom
- 7.4.4. Spain
- 7.4.5. Others
7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. UAE
- 7.5.3. Others
7.6. Asia Pacific
- 7.6.1. China
- 7.6.2. India
- 7.6.3. Japan
- 7.6.4. South Korea
- 7.6.5. Indonesia
- 7.6.6. Thailand
- 7.6.7. Others